SEC Filing Reveals Xoma Corp.'s Pharmaceutical Preparation Activities

Strategic Insights -

Xoma Corp., a pharmaceutical company with operations in Berkeley, CA, filed a Form 4 with the U.S. Securities and Exchange Commission (SEC) on June 1, 2015, detailing the company's pharmaceutical preparation activities. As a company listed under the SIC code 2834, Pharmaceutical Preparations, Xoma Corp. is required to submit regular filings with the SEC. This Form 4 filing provides insight into the company's ownership and stock transactions.

Key Takeaways:

  • Xoma Corp. filed a Form 4 with the SEC on June 1, 2015, revealing the company's pharmaceutical preparation activities under SIC code 2834.
  • The filing reports one document submission and is associated with the SEC file number 0000791908-15-000077.
  • The contact information for Xoma Corp. is 2910 SEVENTH ST, BERKELEY CA 94710, with a phone number of 5106441170.
  • Form 4 requires reporting of changes in ownership and stock transactions for directors, officers, and owners of 10% or more of equity securities.
  • Xoma Corp. is a publicly-traded company submitted to SEC regulations, including regular financial statements and ownership reports.
  • The initial filing is on Form 3, with changes reported on Form 4, and the Annual Statement of beneficial ownership of securities is on Form 5.
  • Xoma Corp.'s pharmaceutical preparation activities are subject to SEC regulations and publicly disclosed through regular filings.

Statistics:

  • SIC code for Xoma Corp.: 2834, Pharmaceutical Preparations
  • SEC file number: 0000791908-15-000077
  • Date of SEC filing: June 1, 2015
  • Contact information: 2910 SEVENTH ST, BERKELEY CA 94710, 5106441170

Sources:

  • U.S. Securities and Exchange Commission (SEC) filing (Form 4)
  • Xoma Corp. (Form 4)
  • SEC filing: http://www.sec.gov/Archives/edgar/data/1210905/0000791908-15-000077-index.html